Announcing the loss of Christy Huff, M.D.
We are devastated to share that on Tuesday, March 5, 2024, we were informed of the passing of our friend, colleague, and Medical Director, Christy Huff, M.D. Many of you know her for her fierce…
-
-
Educating Physician Assistant Students about Benzodiazepines At Eastern Virginia Medical School
We are grateful for the opportunity to educate about benzodiazepines at the Eastern Virginia Medical School’s Physician Assistant Program event! On February 15, 2024, Dr. Michael Bohan, a physician from our Medical Advisory Board, took…
-
Benzo Stories: Martha
Martha shares her story of benzodiazepine harm and healing for our #BenzoStories series.
-
We need more support and doctors that understand the process of tapering
A content analysis of free-text responses to a questionnaire on discontinuing long-term benzodiazepine receptor agonist (BZRA) Use A group of researchers, including Benzodiazepine Information Coalition’s Medical Director, Dr. Christy Huff, along with Tom Lynch, Cristín…
-
Two New Research Opportunities
Two New Research Opportunities Two new research teams are seeking patients impacted by benzodiazepines to discuss their experiences. Both teams are conducting short surveys. If you have taken a benzodiazepine, please consider helping them by…
-
The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs
The first edition of The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids, and Z-drugs is now available! Authored by Mark Horowitz, a Clinical Research Fellow and training psychiatrist with specialized knowledge in deprescribing, along with David Taylor, a Professor of…
-
Benzo Stories: Ryan
Ryan shares his story of benzodiazepine harm and healing for our #BenzoStories series. #BenzoStories is a series by our nonprofit, Benzodiazepine Information Coalition, sharing powerful stories of patient harm associated with prescribed benzodiazepines. To stay…
-
Summarizing the World Health Organization’s 2023 Benzodiazepine Guidelines
On November 20, 2023, the World Health Organization’s (WHO) 2023 (Third Edition) Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological, and substance use disorders introduced revised guidelines. The mhGAP guideline supports countries to…
